Saphenous Vein Graft Occlusion Following Native Vessel Chronic Total Occlusion Percutaneous Coronary Intervention
Whether saphenous vein grafts (SVGs) should be occluded after successful chronic total occlusion (CTO) percutaneous coronary intervention (PCI) of the corresponding native vessel remains controversial. We analyzed the clinical and angiographic characteristics and procedural outcomes of 51 patients w...
Gespeichert in:
| Veröffentlicht in: | The Journal of invasive cardiology 2022-12, Vol.34 (12), p.E836 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 12 |
| container_start_page | E836 |
| container_title | The Journal of invasive cardiology |
| container_volume | 34 |
| creator | Kostantinis, Spyridon Simsek, Bahadir Karacsonyi, Judit Alaswad, Khaldoon Megaly, Michael Jaffer, Farouc A Khatri, Jaikirshan J Poommipanit, Paul Davies, Rhian E Rinfret, Stephane Elbarouni, Basem Ybarra, Luiz F Sheikh, Abdul M Toma, Catalin Chandwaney, Raj Abi Rafeh, Nidal Goktekin, Omer El Guindy, Ahmed M Allana, Salman Mastrodemos, Olga C Rangan, Bavana V Sandoval, Yader Burke, M Nicholas Brilakis, Emmanouil S |
| description | Whether saphenous vein grafts (SVGs) should be occluded after successful chronic total occlusion (CTO) percutaneous coronary intervention (PCI) of the corresponding native vessel remains controversial.
We analyzed the clinical and angiographic characteristics and procedural outcomes of 51 patients who underwent SVG occlusion following successful CTO-PCI of the corresponding native vessel between 2015 and 2022 at 14 centers.
Mean patient age was 71 ± 8 years and 80% were men. The most common CTO target vessel was the right coronary artery (41%), followed by the left circumflex (37%). Retrograde crossing through the SVG was the successful crossing strategy in 40 cases (78%). SVG occlusion was achieved with coils (1.9 ± 1.0) in 35 of 51 patients (69%) and vascular plugs in the other 16 cases (31%). All procedures were technically successful and the SVG was occluded completely (TIMI 0 flow) in 38 of the cases (75%), with the remaining cases having TIMI 1 flow. Follow-up was available for 37 patients (73%); during a mean follow-up of 312 days from CTO-PCI, the incidence of target-lesion failure due to restenosis was 5.4% (n = 2) with no other major events reported.
Following native vessel CTO-PCI, SVG occlusion is often performed and is associated with favorable mid-term outcomes. |
| doi_str_mv | 10.25270/jic/22.00221 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2739430430</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2739430430</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-4d62a1d600a7a6177758e4f7ba4c583f78326c5de6fdaf3894d84ef39e1e45673</originalsourceid><addsrcrecordid>eNpN0M9LwzAUB_AgipvTo1fJ0Uu3_GrSHqW4ORhOcHotWfrqMrqka9qJ_72VTRg8eO_w4cuXh9A9JWMWM0UmW2smjI0JYYxeoCGNYxWxmNDLs3uAbkLY9oTylF6jAZeCypTwIdq_63oDzncBf4J1eNbossVLY6ouWO_w1FeV_7buC7_q1h6gVyFAhbNN4501eOVbXZ35N2hM12oHf4mZ75FufvDctdAcwLU9uUVXpa4C3J32CH1Mn1fZS7RYzubZ0yKqqaBtJArJNC0kIVppSZVScQKiVGstTJzwUiWcSRMXIMtClzxJRZEIKHkKFEQsFR-hx2Nu3fh9B6HNdzYYqKpjuZwpngpO-unpw4l26x0Ued3YXV87_38T_wUE2ms-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2739430430</pqid></control><display><type>article</type><title>Saphenous Vein Graft Occlusion Following Native Vessel Chronic Total Occlusion Percutaneous Coronary Intervention</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Kostantinis, Spyridon ; Simsek, Bahadir ; Karacsonyi, Judit ; Alaswad, Khaldoon ; Megaly, Michael ; Jaffer, Farouc A ; Khatri, Jaikirshan J ; Poommipanit, Paul ; Davies, Rhian E ; Rinfret, Stephane ; Elbarouni, Basem ; Ybarra, Luiz F ; Sheikh, Abdul M ; Toma, Catalin ; Chandwaney, Raj ; Abi Rafeh, Nidal ; Goktekin, Omer ; El Guindy, Ahmed M ; Allana, Salman ; Mastrodemos, Olga C ; Rangan, Bavana V ; Sandoval, Yader ; Burke, M Nicholas ; Brilakis, Emmanouil S</creator><creatorcontrib>Kostantinis, Spyridon ; Simsek, Bahadir ; Karacsonyi, Judit ; Alaswad, Khaldoon ; Megaly, Michael ; Jaffer, Farouc A ; Khatri, Jaikirshan J ; Poommipanit, Paul ; Davies, Rhian E ; Rinfret, Stephane ; Elbarouni, Basem ; Ybarra, Luiz F ; Sheikh, Abdul M ; Toma, Catalin ; Chandwaney, Raj ; Abi Rafeh, Nidal ; Goktekin, Omer ; El Guindy, Ahmed M ; Allana, Salman ; Mastrodemos, Olga C ; Rangan, Bavana V ; Sandoval, Yader ; Burke, M Nicholas ; Brilakis, Emmanouil S</creatorcontrib><description>Whether saphenous vein grafts (SVGs) should be occluded after successful chronic total occlusion (CTO) percutaneous coronary intervention (PCI) of the corresponding native vessel remains controversial.
We analyzed the clinical and angiographic characteristics and procedural outcomes of 51 patients who underwent SVG occlusion following successful CTO-PCI of the corresponding native vessel between 2015 and 2022 at 14 centers.
Mean patient age was 71 ± 8 years and 80% were men. The most common CTO target vessel was the right coronary artery (41%), followed by the left circumflex (37%). Retrograde crossing through the SVG was the successful crossing strategy in 40 cases (78%). SVG occlusion was achieved with coils (1.9 ± 1.0) in 35 of 51 patients (69%) and vascular plugs in the other 16 cases (31%). All procedures were technically successful and the SVG was occluded completely (TIMI 0 flow) in 38 of the cases (75%), with the remaining cases having TIMI 1 flow. Follow-up was available for 37 patients (73%); during a mean follow-up of 312 days from CTO-PCI, the incidence of target-lesion failure due to restenosis was 5.4% (n = 2) with no other major events reported.
Following native vessel CTO-PCI, SVG occlusion is often performed and is associated with favorable mid-term outcomes.</description><identifier>ISSN: 1557-2501</identifier><identifier>EISSN: 1557-2501</identifier><identifier>DOI: 10.25270/jic/22.00221</identifier><identifier>PMID: 36416903</identifier><language>eng</language><publisher>United States</publisher><subject>Aged ; Humans ; Middle Aged ; Percutaneous Coronary Intervention - adverse effects ; Saphenous Vein</subject><ispartof>The Journal of invasive cardiology, 2022-12, Vol.34 (12), p.E836</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36416903$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kostantinis, Spyridon</creatorcontrib><creatorcontrib>Simsek, Bahadir</creatorcontrib><creatorcontrib>Karacsonyi, Judit</creatorcontrib><creatorcontrib>Alaswad, Khaldoon</creatorcontrib><creatorcontrib>Megaly, Michael</creatorcontrib><creatorcontrib>Jaffer, Farouc A</creatorcontrib><creatorcontrib>Khatri, Jaikirshan J</creatorcontrib><creatorcontrib>Poommipanit, Paul</creatorcontrib><creatorcontrib>Davies, Rhian E</creatorcontrib><creatorcontrib>Rinfret, Stephane</creatorcontrib><creatorcontrib>Elbarouni, Basem</creatorcontrib><creatorcontrib>Ybarra, Luiz F</creatorcontrib><creatorcontrib>Sheikh, Abdul M</creatorcontrib><creatorcontrib>Toma, Catalin</creatorcontrib><creatorcontrib>Chandwaney, Raj</creatorcontrib><creatorcontrib>Abi Rafeh, Nidal</creatorcontrib><creatorcontrib>Goktekin, Omer</creatorcontrib><creatorcontrib>El Guindy, Ahmed M</creatorcontrib><creatorcontrib>Allana, Salman</creatorcontrib><creatorcontrib>Mastrodemos, Olga C</creatorcontrib><creatorcontrib>Rangan, Bavana V</creatorcontrib><creatorcontrib>Sandoval, Yader</creatorcontrib><creatorcontrib>Burke, M Nicholas</creatorcontrib><creatorcontrib>Brilakis, Emmanouil S</creatorcontrib><title>Saphenous Vein Graft Occlusion Following Native Vessel Chronic Total Occlusion Percutaneous Coronary Intervention</title><title>The Journal of invasive cardiology</title><addtitle>J Invasive Cardiol</addtitle><description>Whether saphenous vein grafts (SVGs) should be occluded after successful chronic total occlusion (CTO) percutaneous coronary intervention (PCI) of the corresponding native vessel remains controversial.
We analyzed the clinical and angiographic characteristics and procedural outcomes of 51 patients who underwent SVG occlusion following successful CTO-PCI of the corresponding native vessel between 2015 and 2022 at 14 centers.
Mean patient age was 71 ± 8 years and 80% were men. The most common CTO target vessel was the right coronary artery (41%), followed by the left circumflex (37%). Retrograde crossing through the SVG was the successful crossing strategy in 40 cases (78%). SVG occlusion was achieved with coils (1.9 ± 1.0) in 35 of 51 patients (69%) and vascular plugs in the other 16 cases (31%). All procedures were technically successful and the SVG was occluded completely (TIMI 0 flow) in 38 of the cases (75%), with the remaining cases having TIMI 1 flow. Follow-up was available for 37 patients (73%); during a mean follow-up of 312 days from CTO-PCI, the incidence of target-lesion failure due to restenosis was 5.4% (n = 2) with no other major events reported.
Following native vessel CTO-PCI, SVG occlusion is often performed and is associated with favorable mid-term outcomes.</description><subject>Aged</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Percutaneous Coronary Intervention - adverse effects</subject><subject>Saphenous Vein</subject><issn>1557-2501</issn><issn>1557-2501</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpN0M9LwzAUB_AgipvTo1fJ0Uu3_GrSHqW4ORhOcHotWfrqMrqka9qJ_72VTRg8eO_w4cuXh9A9JWMWM0UmW2smjI0JYYxeoCGNYxWxmNDLs3uAbkLY9oTylF6jAZeCypTwIdq_63oDzncBf4J1eNbossVLY6ouWO_w1FeV_7buC7_q1h6gVyFAhbNN4501eOVbXZ35N2hM12oHf4mZ75FufvDctdAcwLU9uUVXpa4C3J32CH1Mn1fZS7RYzubZ0yKqqaBtJArJNC0kIVppSZVScQKiVGstTJzwUiWcSRMXIMtClzxJRZEIKHkKFEQsFR-hx2Nu3fh9B6HNdzYYqKpjuZwpngpO-unpw4l26x0Ued3YXV87_38T_wUE2ms-</recordid><startdate>202212</startdate><enddate>202212</enddate><creator>Kostantinis, Spyridon</creator><creator>Simsek, Bahadir</creator><creator>Karacsonyi, Judit</creator><creator>Alaswad, Khaldoon</creator><creator>Megaly, Michael</creator><creator>Jaffer, Farouc A</creator><creator>Khatri, Jaikirshan J</creator><creator>Poommipanit, Paul</creator><creator>Davies, Rhian E</creator><creator>Rinfret, Stephane</creator><creator>Elbarouni, Basem</creator><creator>Ybarra, Luiz F</creator><creator>Sheikh, Abdul M</creator><creator>Toma, Catalin</creator><creator>Chandwaney, Raj</creator><creator>Abi Rafeh, Nidal</creator><creator>Goktekin, Omer</creator><creator>El Guindy, Ahmed M</creator><creator>Allana, Salman</creator><creator>Mastrodemos, Olga C</creator><creator>Rangan, Bavana V</creator><creator>Sandoval, Yader</creator><creator>Burke, M Nicholas</creator><creator>Brilakis, Emmanouil S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202212</creationdate><title>Saphenous Vein Graft Occlusion Following Native Vessel Chronic Total Occlusion Percutaneous Coronary Intervention</title><author>Kostantinis, Spyridon ; Simsek, Bahadir ; Karacsonyi, Judit ; Alaswad, Khaldoon ; Megaly, Michael ; Jaffer, Farouc A ; Khatri, Jaikirshan J ; Poommipanit, Paul ; Davies, Rhian E ; Rinfret, Stephane ; Elbarouni, Basem ; Ybarra, Luiz F ; Sheikh, Abdul M ; Toma, Catalin ; Chandwaney, Raj ; Abi Rafeh, Nidal ; Goktekin, Omer ; El Guindy, Ahmed M ; Allana, Salman ; Mastrodemos, Olga C ; Rangan, Bavana V ; Sandoval, Yader ; Burke, M Nicholas ; Brilakis, Emmanouil S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-4d62a1d600a7a6177758e4f7ba4c583f78326c5de6fdaf3894d84ef39e1e45673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aged</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Percutaneous Coronary Intervention - adverse effects</topic><topic>Saphenous Vein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kostantinis, Spyridon</creatorcontrib><creatorcontrib>Simsek, Bahadir</creatorcontrib><creatorcontrib>Karacsonyi, Judit</creatorcontrib><creatorcontrib>Alaswad, Khaldoon</creatorcontrib><creatorcontrib>Megaly, Michael</creatorcontrib><creatorcontrib>Jaffer, Farouc A</creatorcontrib><creatorcontrib>Khatri, Jaikirshan J</creatorcontrib><creatorcontrib>Poommipanit, Paul</creatorcontrib><creatorcontrib>Davies, Rhian E</creatorcontrib><creatorcontrib>Rinfret, Stephane</creatorcontrib><creatorcontrib>Elbarouni, Basem</creatorcontrib><creatorcontrib>Ybarra, Luiz F</creatorcontrib><creatorcontrib>Sheikh, Abdul M</creatorcontrib><creatorcontrib>Toma, Catalin</creatorcontrib><creatorcontrib>Chandwaney, Raj</creatorcontrib><creatorcontrib>Abi Rafeh, Nidal</creatorcontrib><creatorcontrib>Goktekin, Omer</creatorcontrib><creatorcontrib>El Guindy, Ahmed M</creatorcontrib><creatorcontrib>Allana, Salman</creatorcontrib><creatorcontrib>Mastrodemos, Olga C</creatorcontrib><creatorcontrib>Rangan, Bavana V</creatorcontrib><creatorcontrib>Sandoval, Yader</creatorcontrib><creatorcontrib>Burke, M Nicholas</creatorcontrib><creatorcontrib>Brilakis, Emmanouil S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of invasive cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kostantinis, Spyridon</au><au>Simsek, Bahadir</au><au>Karacsonyi, Judit</au><au>Alaswad, Khaldoon</au><au>Megaly, Michael</au><au>Jaffer, Farouc A</au><au>Khatri, Jaikirshan J</au><au>Poommipanit, Paul</au><au>Davies, Rhian E</au><au>Rinfret, Stephane</au><au>Elbarouni, Basem</au><au>Ybarra, Luiz F</au><au>Sheikh, Abdul M</au><au>Toma, Catalin</au><au>Chandwaney, Raj</au><au>Abi Rafeh, Nidal</au><au>Goktekin, Omer</au><au>El Guindy, Ahmed M</au><au>Allana, Salman</au><au>Mastrodemos, Olga C</au><au>Rangan, Bavana V</au><au>Sandoval, Yader</au><au>Burke, M Nicholas</au><au>Brilakis, Emmanouil S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Saphenous Vein Graft Occlusion Following Native Vessel Chronic Total Occlusion Percutaneous Coronary Intervention</atitle><jtitle>The Journal of invasive cardiology</jtitle><addtitle>J Invasive Cardiol</addtitle><date>2022-12</date><risdate>2022</risdate><volume>34</volume><issue>12</issue><spage>E836</spage><pages>E836-</pages><issn>1557-2501</issn><eissn>1557-2501</eissn><abstract>Whether saphenous vein grafts (SVGs) should be occluded after successful chronic total occlusion (CTO) percutaneous coronary intervention (PCI) of the corresponding native vessel remains controversial.
We analyzed the clinical and angiographic characteristics and procedural outcomes of 51 patients who underwent SVG occlusion following successful CTO-PCI of the corresponding native vessel between 2015 and 2022 at 14 centers.
Mean patient age was 71 ± 8 years and 80% were men. The most common CTO target vessel was the right coronary artery (41%), followed by the left circumflex (37%). Retrograde crossing through the SVG was the successful crossing strategy in 40 cases (78%). SVG occlusion was achieved with coils (1.9 ± 1.0) in 35 of 51 patients (69%) and vascular plugs in the other 16 cases (31%). All procedures were technically successful and the SVG was occluded completely (TIMI 0 flow) in 38 of the cases (75%), with the remaining cases having TIMI 1 flow. Follow-up was available for 37 patients (73%); during a mean follow-up of 312 days from CTO-PCI, the incidence of target-lesion failure due to restenosis was 5.4% (n = 2) with no other major events reported.
Following native vessel CTO-PCI, SVG occlusion is often performed and is associated with favorable mid-term outcomes.</abstract><cop>United States</cop><pmid>36416903</pmid><doi>10.25270/jic/22.00221</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1557-2501 |
| ispartof | The Journal of invasive cardiology, 2022-12, Vol.34 (12), p.E836 |
| issn | 1557-2501 1557-2501 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2739430430 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Aged Humans Middle Aged Percutaneous Coronary Intervention - adverse effects Saphenous Vein |
| title | Saphenous Vein Graft Occlusion Following Native Vessel Chronic Total Occlusion Percutaneous Coronary Intervention |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T22%3A47%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Saphenous%20Vein%20Graft%20Occlusion%20Following%20Native%20Vessel%20Chronic%20Total%20Occlusion%20Percutaneous%20Coronary%20Intervention&rft.jtitle=The%20Journal%20of%20invasive%20cardiology&rft.au=Kostantinis,%20Spyridon&rft.date=2022-12&rft.volume=34&rft.issue=12&rft.spage=E836&rft.pages=E836-&rft.issn=1557-2501&rft.eissn=1557-2501&rft_id=info:doi/10.25270/jic/22.00221&rft_dat=%3Cproquest_pubme%3E2739430430%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2739430430&rft_id=info:pmid/36416903&rfr_iscdi=true |